Overview
Healthcare financial solutions firm's H1 FY26 revenue grew 6% yr/yr
Adjusted EBITDA rose 10% and adjusted EPS grew 16% yr/yr
Company plans a $25 mln share buyback program
Outlook
Company expects FY26 results in line with market expectations
Craneware sees considerable long-term growth opportunities due to strong market positioning
High levels of expansion sales and 340B Shelter opportunity to drive positive H2 performance
Result Drivers
NEW CUSTOMER SALES - Sales to new customers increased to 12% of total sales, reflecting higher competitive take-out rate and future expansion potential
MICROSOFT PARTNERSHIP - Collaboration with Microsoft enhanced AI capabilities, leading to accelerated innovation and new Trisus functionality
340B REBATE MODEL - Despite postponement, 340B Rebate model demonstrated Craneware's ability to adapt and provide integrated solutions, supporting future growth
Company press release: ID:nRSB8151Ua
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 Revenue | $105.70 mln | ||
H1 Gross Profit | $89.67 mln | ||
H1 Operating Expenses | -$75.44 mln | ||
H1 Operating Profit | $13.32 mln | ||
H1 Pretax Profit | $13 mln |
Analyst Coverage
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the software peer group is "buy."
Wall Street's median 12-month price target for Craneware PLC is GBp2,885.50, about 90.5% above its February 27 closing price of GBp1,515.00
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 23 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Comments